EP Patent

EP1938839A1 — Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia

Assigned to Individual · Expires 2008-07-02 · 18y expired

What this patent protects

Ophthalmic compositions for the treatment of presbyopia, comprising combinations of parasympathomimetics andnon-steroidal anti-inflammatories.

USPTO Abstract

Ophthalmic compositions for the treatment of presbyopia, comprising combinations of parasympathomimetics andnon-steroidal anti-inflammatories.

Drugs covered by this patent

pilocarpine-hydrochloride (PILOCARPINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP1938839A1
Jurisdiction: EP
Classification: —
Expires: 2008-07-02
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.